⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATYR News
aTyr Pharma, Inc. Common Stock
Pomerantz LLP Advises Shareholders of Class Action Against aTyr Pharma, Inc. – ATYR
accessnewswire.com
ATYR
Class Action Alert: Levi & Korsinsky Reminds aTyr (ATYR) Investors of December 8, 2025 Deadline
accessnewswire.com
ATYR
ATYR INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ATYR To Contact Him Directly To Discuss Their Options
prnewswire.com
ATYR
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR
prnewswire.com
ATYR
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
ATYR
aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR
prnewswire.com
ATYR
Pomerantz LLP Advises Shareholders of Class Action Against aTyr Pharma, Inc. – ATYR
accessnewswire.com
ATYR
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATYR
accessnewswire.com
ATYR
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
prnewswire.com
ATYR
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
prnewswire.com
ATYR